针刺联合通络明目汤在糖尿病视网膜病变激光术后的应用

doi:10.3760/cma.j.cn441417-20241008-11020

摘要/Abstract

摘要：

目的　探讨通阳开窍法针刺联合通络明目汤对糖尿病视网膜病变激光术后视功能、黄斑区微血管的影响。方法　选取济南市第二人民医院2022年1月至2024年5月收治的糖尿病视网膜病变激光术后患者共172例开展前瞻性随机对照试验，根据随机数字表法分为4组，各43例。对照组男20例、女23例，年龄（65.77±8.10）岁，糖尿病病程（10.07±2.15）年，患眼78只；A组男22例、女21例，年龄（66.05±8.26）岁，糖尿病病程（10.12±2.10）年，患眼76只；B组男21例、女22例，年龄（65.53±8.07）岁，糖尿病病程（10.16±2.08）年，患眼75只；C组男19例、女24例，年龄（65.44±8.12）岁，糖尿病病程（10.21±2.18）年，患眼76只。对照组予以基础支持治疗，A组予以通阳开窍法针刺+基础支持治疗，B组予以通络明目汤+基础支持治疗，C组予以通阳开窍法针刺+通络明目汤+基础支持治疗。4组均治疗2周。比较各组治疗前后中医症状评分、视功能、黄斑区微血管参数变化及不良反应。采用One-way ANOVA检验、χ2检验对数据进行统计学分析。结果　治疗2周后，C组中医症状评分的主症评分、次症评分、总分以及视网膜新生血管（RNV）渗漏面积、黄斑中心凹厚度（CMT）均低于A、B、对照组［（3.15±0.75）分比（5.12±1.01）分、（5.02±1.00）分、（7.35±1.20）分；（2.24±0.41）分比（3.45±0.71）分、（3.26±0.68）分、（4.09±0.81）分；（5.39±1.05）分比（8.57±1.75）分、（8.29±1.69）分、（10.95±2.01）分；（221.04±19.60）mm2比（261.20±21.32）mm2、（259.74±20.53）mm2、（281.75±25.66）mm2；（422.17±35.88）µm比（455.86±37.64）µm、（451.33±38.76）µm、（474.82±39.41）µm］，A、B组均低于对照组，差异均有统计学意义（均P<0.05）；C组的最佳矫正视力（BCVA）、深层毛细血管丛血流密度（DCP-BD）均高于A、B、对照组［（0.78±0.14）°比（0.62±0.11）°、（0.64±0.12）°、（0.55±0.10）°；（45.07±2.04）%比（43.10±2.05）%、（43.12±2.07）%、（41.03±2.01）%］，A、B组均高于对照组，差异均有统计学意义（均P<0.05）。对照组、A、B、C组不良反应发生率分别为4.65%（2/43）、9.52%（4/42）、11.90%（5/42）、14.63%（6/41）］，差异无统计学意义（校正χ2=0.448，P=0.569）。结论　通阳开窍法针刺、通络明目汤均可减轻糖尿病视网膜病变激光术后患者的临床症状，并改善视功能和黄斑区DCP-BD，二者联合治疗效果更理想，且安全可靠。

关键词: 针刺, 通络明目汤, 糖尿病视网膜病变, 激光术, 视功能, 黄斑区微血管

Abstract:

Objective　To investigate the effects of acupuncture using the Tongyang Kaiqiao method combined with Tongluo Mingmu decoction on visual function and microvascular parameters in the macular region after laser surgery for diabetic retinopathy. Methods　A total of 172 patients who underwent laser surgery for diabetic retinopathy at Jinan Second People's Hospital from January 2022 to May 2024 were selected for a prospective randomized controlled trial, divided into four groups using a random number table. The control group comprised 20 males and 23 females, with an average age of (65.77±8.10) years and a diabetes duration of (10.07±2.15) years, involving 78 affected eyes. Group A consisted of 22 males and 21 females, with an average age of (66.05±8.26) years and a diabetes duration of (10.12±2.10) years, involving 76 affected eyes. Group B included 21 males and 22 females, with an average age of (65.53±8.07) years and a diabetes duration of (10.16±2.08) years, involving 75 affected eyes. Group C comprised 19 males and 24 females, with an average age of (65.44±8.12) years and a diabetes duration of (10.21±2.18) years, involving 76 affected eyes. The control group received basic supportive treatment, while Group A received acupuncture using the Tongyang Kaiqiao method plus basic supportive treatment, Group B received Tongluo Mingmu decoction plus basic supportive treatment, and Group C received acupuncture using the Tongyang Kaiqiao method plus Tongluo Mingmu decoction plus basic supportive treatment. All groups were treated for 2 weeks. The changes in Traditional Chinese Medicine (TCM) symptom scores, visual function, and microvascular parameters in the macular region before and after treatment were compared, along with adverse reactions. Statistical analysis was performed using One-way ANOVA and χ² tests. Results　After 2 weeks of treatment, the main symptom scores, secondary symptom scores, total scores, retinal neovascularization (RNV) leakage area, and central macular thickness (CMT) in Group C were lower than those in Groups A, B, and the control group [(3.15±0.75) points vs. (5.12±1.01) points, (5.02±1.00) points, (7.35±1.20) points; (2.24±0.41) points vs. (3.45±0.71) points, (3.26±0.68) points, (4.09±0.81) points; (5.39±1.05)points vs. (8.57±1.75) points, (8.29±1.69) points, (10.95±2.01) points; (221.04±19.60) mm² vs. (261.20±21.32) mm², (259.74±20.53) mm², (281.75±25.66) mm²; (422.17±35.88) µm vs. (455.86±37.64) µm, (451.33±38.76) µm, (474.82±39.41) µm], with statistically significant differences (all P<0.05). Groups A and B also had lower scores compared to the control group, with significant differences (all P<0.05). The best corrected visual acuity (BCVA) and deep capillary plexus blood flow density (DCP-BD) in Group C were higher than those in Groups A, B, and the control group [(0.78±0.14)° vs. (0.62±0.11)°, (0.64±0.12)°, (0.55±0.10)°; (45.07±2.04)% vs. (43.10±2.05)%, (43.12±2.07)%, (41.03±2.01)%], with significant differences (all P<0.05). The incidence of adverse reactions in the control, A, B, and C groups was 4.65% (2/43), 9.52% (4/42), 11.90% (5/42), and 14.63% (6/41), respectively, with no statistically significant difference (corrected χ²=0.448, P=0.569). Conclusion　Both acupuncture using the Tongyang Kaiqiao method and Tongluo Mingmu decoction can alleviate symptoms after laser surgery for diabetic retinopathy, improve visual function, and enhance DCP-BD in the macular region. Their combined application yields even better results and is safe and reliable.

Key words: Acupuncture, , Tongluo Mingmu , decoction, , Diabetes retinopathy, , Laser technology, , Visual function, , Microvasculature in macular area

杨奕王丽黄辉胥丽辉. 针刺联合通络明目汤在糖尿病视网膜病变激光术后的应用 [J]. 国际医药卫生导报, 2025, 31(11): 1869-1874.

Yang Yi, Wang Li, Huang Hui, Xu Lihui.

Application of acupuncture combined with Tongluo Mingmu decoction after laser surgery for diabetes retinopathy [J]. International Medicine and Health Guidance News, 2025, 31(11): 1869-1874.

参考文献

[1]王满华,张韬,张永刚.化瘀复明汤联合羟苯磺酸钙治疗糖尿病视网膜病变患者的疗效观察[J].国际医药卫生导报,2024,30(7):1136-1141. DOI:10.3760/cma.j.issn.1007-1245.2024.07.016.

[2]Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus[J]. Nat Rev Endocrinol, 2022, 18(9): 525-539. DOI: 10.1038/s41574-022-00690-7.

[3]Chen Y, Xiang X, Wu Y, et al. Magnesium depletion score predicts diabetic retinopathy risk among diabetes: findings from NHANES 2005-2018[J]. Biol Trace Elem Res, 2023, 201(6): 2750-2756. DOI: 10.1007/s12011-022-03384-3.

[4]Kousha O, Staniszewski B, Ulloa JL, et al. Frugal retinal laser training simulation eyes[J]. Eye (Lond), 2022, 36(5): 1129-1130. DOI: 10.1038/s41433-021-01590-2.

[5]Zou YH, She KQ, Ren JN, et al. Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome[J]. Int J Ophthalmol, 2022, 15(5):766-772. DOI: 10.18240/ijo.2022.05.12.

[6]赵云,张珍丽,吕娜.通阳开窍法针刺对非增生性糖尿病视网膜病变患者VEGF、 sICAM-1、TNF-α因子的影响[J].国医论坛,2022,37(6):21-23. DOI:10.13913/j.cnki.41-1110/r.2022.06.021.

[7]王露露,廖良,张陶陶,等.通络复明方对糖尿病视网膜病变激光术后视功能恢复的影响[J].南京中医药大学学报,2020,36(5):767-771. DOI:10.14148/j.issn.1672-0482.2020.0767.

[8]中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014,50(11):851-865. DOI:10.3760/cma.j.issn.0412-4081.2014.11.014.

[9]段俊国.中西医结合眼科学[M].北京:中国中医药出版社, 2013: 110-111.

[10]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409. DOI:10.3760/cma.j.cn115791-20210221-00095.

[11]国家中医药管理局.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社, 2002:151-153.

[12]许迅,沈胤忱. ETDRS视力表在临床研究中的作用[C]//第十四届国际眼科学学术会议、第十四届国际视光学学术会议暨第三届国际角膜塑形学术大会论文集. 2014:272-273.

[13]Gao SS, Jia Y, Zhang M, et al. Optical Coherence Tomography Angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9): OCT27-36. DOI: 10.1167/iovs.15-19043.

[14]Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med, 2022, 54(1): 1089-1111. DOI: 10.1080/07853890.2022.2064541.

[15]Castellanos-Canales D, Fawzi AA. Global challenges in the management of diabetic retinopathy in women with pre-gestational diabetes[J]. Clin Exp Ophthalmol, 2022, 50(7): 711-713. DOI: 10.1111/ceo.14173.

[16]Feng L, Liang L, Zhang S, et al. HMGB1 downregulation in retinal pigment epithelial cells protects against diabetic retinopathy through the autophagy-lysosome pathway[J]. Autophagy, 2022, 18(2):320-339. DOI: 10.1080/15548627.2021.1926655.

[17]熊萌,曾梅艳,宋厚盼,等.基于现代文献分析的糖尿病视网膜病变中医证型及证素分布探讨[J].广州中医药大学学报,2023,40(3):761-768. DOI:10.13359/j.cnki.gzxbtcm.2023.03.037.

[18]江婕妤,吕怡,刘志敏,等.基于络脉理论探析养阴清热、活血利水法治疗DR激光损伤[J].中国中医眼科杂志,2023,33(5):468-471. DOI:10.13444/j.cnki.zgzyykzz.2023.05.014.

[19]杨赞章,张越,毛爱玲,等.基于目络学说探讨糖尿病视网膜病变辨证思路与治疗[J].中华中医药杂志,2023,38(6):2672-2675.

[20]张芳玲,王玉红,潘天鸿,等.枸杞多糖对N-甲基-D-天冬氨酸诱导的视网膜光感受器细胞损伤的保护作用[J].中国临床药理学杂志,2024,40(14):2058-2062. DOI:10.13699/j.cnki.1001-6821.2024.14.012.

[21]蒋鹏飞,欧晨,彭俊,等.枸杞子-丹参对rd10小鼠视网膜Caspase-8、 Caspase-12、Caspase-3、αB-crystallin表达的影响[J].中国中医药信息杂志,2022,29(2):48-54. DOI:10.19879/j.cnki.1005-5304.202105502.

[22]冯媛,陈艳玲,刘伦志.针刺联合中西药治疗糖尿病视网膜病变的疗效观察[J].上海针灸杂志,2022,41(11):1065-1070. DOI:10.13460/j.issn.1005-0957.2022.11.1065.

[23]韩其琛,孙忠人,尹洪娜,等.基于数据挖掘分析针灸治疗糖尿病视网膜病变的选穴规律[J].针灸临床杂志,2022,38(12):48-52. DOI:10.19917/j.cnki.1005-0779.022230.

[24]陈鹏,贺翔鸽.丹参对糖尿病视网膜病变患者视觉功能的改善与治疗前后自由基水平变化[J].中国临床康复,2005,9(25):157-158. DOI:10.3321/j.issn:1673-8225.2005.25.084.

[25]李思远,司赵宏,张智敏,等.基于网络药理学与分子对接探究黄芪-葛根-丹参治疗糖尿病视网膜病变的作用机制[J].特产研究,2023,45(2):11-19. DOI:10.16720/j.cnki.tcyj.2023.036.

[26]高优歌,王艳歌,宋宗明.视网膜色素上皮细胞来源的细胞外囊泡在年龄相关性黄斑变性发病机制中的作用[J].中华实验眼科杂志,2024,42(9):876-880. DOI:10.3760/cma.j.cn115989-20230626-00022.